Markets.com Logo

ACTQTX

$--
--%
1d
1w
1m

Analysis and statistics

  • Open
    553.5665$
  • Previous Close
    553.5665$
  • 52 Week Change
    --
  • Day Range
    0.00$
  • 52 Week High/Low
    --
  • Dividend Per Share
    --
  • Market cap
    --$
  • EPS
    --
  • Beta
    --
  • Volume
    --

About

ACTQTX.US represents shares of Actuate Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on developing therapies for cancers that no longer respond to conventional treatments. Their lead drug candidate, elraglusib, is a small molecule inhibitor of glycogen synthase kinase-3 beta (GSK-3β) and is being evaluated in multiple clinical trials for various cancer types, including advanced sarcomas and metastatic pancreatic cancer. Investment in Actuate Therapeutics carries inherent risks associated with drug development, regulatory approvals, and market competition within the pharmaceutical industry.
OKLO Releases Q2 2025 Earnings: What to Know about OKLO Stock?

OKLO Releases Q2 2025 Earnings: What to Know about OKLO Stock?

Frances Wang|--
 SMCI Stock Analysis: What’s Happening with Super Micro Computer?

SMCI Stock Analysis: What’s Happening with Super Micro Computer?

Frances Wang|--
Nasdaq 100 Index ETFs to Watch: QQQ, QQQM, TQQQ

Nasdaq 100 Index ETFs to Watch: QQQ, QQQM, TQQQ

Frances Wang|--

Wall Street's Reaction to Trump's Fed Nominee Miran: A Look at Potential Monetary Policy Shifts

Emma Rose|--

US Inflation Data: A Critical Market Catalyst

Noah Lee|--
Bitcoin Price Prediction: Could BTC Hit $1 Million in 2025?

Bitcoin Price Prediction: Could BTC Hit $1 Million in 2025?

Ghko B|--
Aerodrome Finance Price Analysis: Why Is AERO Price up Today?

Aerodrome Finance Price Analysis: Why Is AERO Price up Today?

Ghko B|--

Factors

Company Performance: Strong earnings reports, positive clinical trial results, or successful product launches typically increase the stock price.

Industry Trends: Growth in the biotechnology sector, increasing demand for gene editing therapies, or favorable regulatory changes can boost investor confidence.

Market Sentiment: General optimism or pessimism in the stock market, risk appetite among investors, and overall economic conditions influence trading activity.

Competitor Activities: Successes or failures of competing companies in similar therapeutic areas can impact investor perception and stock valuation.

Regulatory Approvals: Positive decisions from regulatory bodies like the FDA regarding drug approvals or clinical trial protocols drive the stock price up.

News and Events: Significant announcements, partnerships, acquisitions, or scientific breakthroughs related to the company or its technology affect investor reaction.

People Also Watch

Latest news

US CPI Data July: A Risky Economic Outlook Unveiled

Ava Grace|--
Morning Note: RBA Rate Cut; US CPI Awaited; Ethereum Rallies on Inflows

Morning Note: RBA Rate Cut; US CPI Awaited; Ethereum Rallies on Inflows

Tommy Yap|--
Stock Market Today: Dow Fluctuates as Trump Extends China Tariff Deadline

Stock Market Today: Dow Fluctuates as Trump Extends China Tariff Deadline

Ghko B|--

Latest Education Articles

Crypto CFD Trading: Bitcoin CFD, Solana CFD, MAGACOIN CFD

Crypto CFD Trading: Bitcoin CFD, Solana CFD, MAGACOIN CFD

Ghko B|--
SoFi Stock Jumped: How to Trade SoFi Stock CFD online?

SoFi Stock Jumped: How to Trade SoFi Stock CFD online?

Frances Wang|--
Trending Stock CFDs: CRWV Stock CFDs, NBIS Stock CFDs, TEM Stock CFDs

Trending Stock CFDs: CRWV Stock CFDs, NBIS Stock CFDs, TEM Stock CFDs

Frances Wang|--